Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

11-OH-Δ8-THC11-Hydroxy-Δ8-tetrahydrocannabinol

Active metabolite of Δ8-THC, counterpart of 11-OH-THC; formed in much smaller amounts at equal dose.

Level of detail

C₂₁H₃₀O₃

CAS 28646-40-4

Family
Metabolite
Molar mass
330.47 g/mol

Updated on

In plain terms

11-OH-Δ8-THC is the molecule the body makes from delta-8-THC, and it too binds the brain's cannabinoid receptor. In a 2025 trial with brownies, its blood level after 20 mg of delta-8 was clearly lower than that of the 11-OH-THC formed from 20 mg of regular THC.

Receptors and activity

Target network

CB1Binding (function not established)Ki = 52 nM · bovine[3H]CP-55940 displacement, bovine cortex; competitive inhibition
  • Binds or modulates

The lower the cited value, the closer the target sits to 11-OH-Δ8-THC: one ring per factor of 100. A target with no measured value stays on the edge.

Where these targets live

Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of 11-OH-Δ8-THC.

Brain, side view
Body, front view
Blood

CB1CB1 found in 7 regions of the body

  1. Basal gangliadenseMost dense in basal ganglia outflow nuclei1
  2. CerebellumdenseVery dense in the cerebellum1
  3. HippocampusdenseVery high concentrations in the hippocampus2
  4. AmygdaladenseHigh concentrations in the amygdala2
  5. CortexpresentPresent throughout the neocortex2
  6. Adipose tissuepresentExpressed in adipose tissue3
  7. GutpresentColonic epithelium, smooth muscle and plexus4

Cited values

  1. CB1Binding (function not established)Ki = 52 nM · bovine55 out of 100

    Yamamoto I et al. 1998, Biol Pharm Bull (new tab) · [3H]CP-55940 displacement, bovine cortex; competitive inhibition

Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

Pharmacology

11-Hydroxy-Δ8-tetrahydrocannabinol is the 11-hydroxylated metabolite of Δ8-THC, counterpart of 11-OH-THC in the Δ9 series. Foltz et al. identified it in 1970 as the major metabolite of Δ8-THC, in vivo and in liver microsomes, and observed behavioural effects in rats similar to those of THC. It binds the cannabinoid receptor of bovine cortex with a Ki of 52 nM (Yamamoto et al. 1998). Its formation is catalysed mainly by CYP2C9, whose *2, *3, *8 and *9 variants reduce activity 20- to 60-fold (Zhao and Lazarus 2026). In a double-blind crossover trial in 19 adults, blood concentrations of the metabolite after 20 mg of oral Δ8-THC were clearly lower than those of 11-OH-THC after 20 mg of Δ9-THC, and Δ8-THC was less potent at equal dose (Zamarripa et al. 2025). In mice, it is oxidised to 11-oxo-Δ8-THC and then to Δ8-THC-11-oic acid, which binds the receptor poorly.

Key sources.

History

Source
No presence in the cannabis plant is documented. 11-OH-Δ8-THC forms in the body as a phase I metabolite of Δ8-THC; it is also prepared in the laboratory as an analytical standard. The Δ8-THC in market products is itself usually obtained by chemical conversion of CBD (EMCDDA 2023).

Metabolic pathway

No plant pathway: the molecule arises from hydroxylation of the 11-methyl group of Δ8-THC by the microsomal mono-oxygenase system (Watanabe et al. 1981). With recombinant enzymes, CYP2C9 shows an intrinsic clearance more than 6,200 times that of CYP2C19, the only other active CYP tested; the authors name it the main enzyme of this hydroxylation in the intestine, while other CYPs may contribute in the liver. The CYP2C9*2, *3, *8 and *9 variants reduce activity 20- to 60-fold (Zhao and Lazarus 2026).

Classification

Family, origin and source verification

Family

Metabolite

Chemistry

C5 side chain · neutral form

Parent molecule

Δ8-THC

Active metabolite.

Verification

Every fact on this entry was checked against its primary sources on 20 October 2026.

Wikipedia (English)

11-Hydroxy-Δ8-THC (new tab)

Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

References

  1. Foltz RL, Fentiman AF Jr et al. Metabolite of (−)-trans-Δ8-tetrahydrocannabinol: identification and synthesis. Science 1970;168:844-5 (new tab)PMID 5444059
  2. Watanabe K, Yamamoto I, Oguri K, Yoshimura H. Metabolic disposition of Δ8-tetrahydrocannabinol and its active metabolites, 11-hydroxy-Δ8-THC and 11-oxo-Δ8-THC, in mice. Drug Metab Dispos 1981;9:261-4 (new tab)PMID 6113937
  3. Yamamoto I, Kimura T, Kamei A et al. Competitive inhibition of Δ8-tetrahydrocannabinol and its active metabolites for cannabinoid receptor binding. Biol Pharm Bull 1998;21:408-10 (new tab)PMID 9586583
  4. Järbe TU, McMillan DE. Δ9-THC as a discriminative stimulus in rats and pigeons: generalization to THC metabolites and SP-111. Psychopharmacology (Berl) 1980;71:281-9 (new tab)PMID 6256796
  5. Zamarripa CA, Spindle TR, Schriefer D et al. A within-subject cross-over trial comparing the acute effects of oral Δ8-THC and Δ9-THC in healthy adults. Drug Alcohol Depend 2025;272:112676 (new tab)PMID 40288059
  6. Zhao M, Lazarus P. Cytochrome P450-catalyzed hydroxylation of Δ8-tetrahydrocannabinol and implications for pharmacogenetics. Pharmaceutics 2026;18:1149 (new tab)PMID 42797324
  7. Chan-Hosokawa A, Nguyen L, Lattanzio N, Adams WR. Emergence of delta-8 tetrahydrocannabinol in DUID investigation casework: method development, validation and application. J Anal Toxicol 2022;46:1-9 (new tab)PMID 33754645
  8. EMCDDA (Ujváry I. et al.), Hexahydrocannabinol (HHC) and related substances, technical report, 2023 (new tab)
  9. ANSM, decision of 22 May 2024 amending the list of substances classified as narcotics (generic benzo[c]chromene class), supplemented by the decision of 3 June 2024 (new tab)
  10. ANSM, decision of 6 February 2026 amending the list of substances classified as narcotics and the list of psychotropic substances (tetrahydrocannabinols in annex III) (new tab)
  11. ANSM, consolidated list of substances classified as narcotics, updated 26/06/2026 (new tab)

Identifiers

Names

Common name
11-Hydroxy-Δ8-tetrahydrocannabinol
IUPAC name
(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
Other names
11-OH-Δ8-THC · 11-hydroxy-delta-8-THC · 11-OH-delta8-THC · 7-OH-Δ6-THC

Identifiers

Formula
C₂₁H₃₀O₃
CAS
28646-40-4
PubChem CID
185651(new tab)
InChIKey
LOUSQMWLMDHRIK-IAGOWNOFSA-N
SMILES
CCCCCC1=CC(=C2[C@@H]3CC(=CC[C@H]3C(OC2=C1)(C)C)CO)O

Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.